By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
24x7Report24x7Report
  • Home
  • World News
  • Finance
  • Sports
  • Beauty
  • Fashion
  • Fitness
  • Gadgets
  • Travel
Search
© 2023 News.24x7report.com - All Rights Reserved.
Reading: Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)’s Weight Loss Pill
Share
Aa
24x7Report24x7Report
Aa
Search
  • Home
  • World News
  • Finance
  • Sports
  • Beauty
  • Fashion
  • Fitness
  • Gadgets
  • Travel
  • en English
    • en English
    • id Indonesian
    • ms Malay
    • es Spanish
Follow US
© 2023 News.24x7report.com - All Rights Reserved.
24x7Report > Blog > Finance > Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)’s Weight Loss Pill
Finance

Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)’s Weight Loss Pill

Last updated: 2026/01/02 at 11:06 AM
Share
3 Min Read
Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)’s Weight Loss Pill
SHARE

We recently published 10 Stocks on Jim Cramer’s Radar.  Novo Nordisk A/S (NYSE:NVO) is one of the stocks on Jim Cramer’s radar.

Danish pharmaceutical firm Novo Nordisk A/S (NYSE:NVO) scored a major win earlier this month after it secured the Food and Drug Administration’s (FDA) approval for its weight loss pill. The approval made the Wegovy pill the first of its kind, and it led to the firm’s shares closing 7.30% higher. The approval marked a key win for Novo Nordisk A/S (NYSE:NVO) as the firm has reportedly struggled against Eli Lilly in the weight loss drug market. Following the Wegovy pill approval, the pharmaceutical company moved fast, as a report from the Chinese outlet Yicai suggested that Novo Nordisk A/S (NYSE:NVO) had cut the prices of its highest dosage Wegovy drugs in half in some Chinese provinces. After the approval, BMO Capital reiterated a Market Perform rating and a $46 share price target for the company. The financial firm outlined that Novo Nordisk A/S (NYSE:NVO) could benefit from a first-mover advantage in the oral weight loss drug market and added that it could face competitive challenges in the future. Cramer shared his own unique take on the matter, as he commented that Novo Nordisk A/S (NYSE:NVO) might see resistance from physicians when it comes to taking away market share from Eli Lilly:

Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)'s Weight Loss Pill
Jim Cramer Shares Key Caveat For Novo Nordisk (NVO)’s Weight Loss Pill

“Now, remember, that a pill is much preferred in the country, versus the shot. If you are taking Wegovy, then people will move over, quickly migrate over to Wegovy pill. . .let’s say you are taking Mounjaro right now, Eli Lilly, they are reluctant to say listen you should go do Wegovy. Because what they’ll say is listen, you tolerate Mounjaro, and we just care about toleration. And that’s been the way things go. And I think people who think, wow, there are people who are going to be really excited to move over to the pill. Their advice from the doctors is going to be, no, there could be different reactions. And apparently the doses are so high, that there are some different changes in diet that you might have to do. We don’t know enough about what the side effects are, we know this. The profession just doesn’t like you to switch from one drug to another.

See also  I Just Retired At 62 With $980K Between My 401(k), Roth IRA, And Brokerage Account—Which Do I Tap First So I Don't Get Crushed on Taxes?

You Might Also Like

5 Key Points for Plastic Surgery Consultations You Need

PRP Injections for Hair Loss: Miracle or Myth?

NFL overreactions: Panthers’ loss raises Bryce Young concerns, Ravens in danger

6 Key Insights Women Must Know Before a Breast Lift

The US and China Cannot Slow the AI Race, But They Can Make It Safer

TAGGED: Caveat, Cramer, Jim, key, Loss, Nordisk, Novo, NVOs, Pill, Shares, Weight

Sign Up For Daily Newsletter

Be keep up! Get the latest breaking news delivered straight to your inbox.
[mc4wp_form]
By signing up, you agree to our Terms of Use and acknowledge the data practices in our Privacy Policy. You may unsubscribe at any time.
Share this Article
Facebook Twitter Copy Link Print
Previous Article Bella Hadid Does Naked Dressing the Aspen Way
Next Article Disney World Worker Is Injured Trying To Stop Runaway Boulder At Indiana Jones Show Disney World Worker Is Injured Trying To Stop Runaway Boulder At Indiana Jones Show

Stay Connected

1.30M Followers Like
311 Followers Pin
766 Followers Follow

Latest News

4 Mindblowing Festive Winter Destinations In Europe Everyone Should Visit At Least Once—From Markets In Ancient Caves To Flying Santas
4 Mindblowing Festive Winter Destinations In Europe Everyone Should Visit At Least Once—From Markets In Ancient Caves To Flying Santas
Travel November 18, 2026
Samsung Galaxy Tab S12 Ultra review: Where do we go from here?
Gadgets November 18, 2026
Prisco’s NFL Week 11 Power Rankings: Patrick Mahomes returns to MVP form, which makes Chiefs scary
Sports November 17, 2026
Americans Can Now Fly Direct To This Stunning Transylvanian City With A 14th-Century Church, $10 Dinners, And Smaller Crowds
Americans Can Now Fly Direct To This Stunning Transylvanian City With A 14th-Century Church, $10 Dinners, And Smaller Crowds
Travel November 15, 2026
Soundpeats Air6 Pro Review – Affordable ANC Earbuds with Premium Features – Mighty Gadget Blog Technology News and Reviews
Gadgets November 14, 2026
//

This is your World, Finance, Fitness, Fashion  Sports  website. We provide the latest breaking news straight from the News industry.

Quick Link

  • About Us
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Sitemap

Top Categories

  • Fashion
  • Finance
  • Fitness
  • Gadgets
  • Travel

Sign Up for Our Newsletter

Subscribe to our newsletter to get our newest articles instantly!


24x7Report24x7Report
Follow US

Copyright © 2025 Adways VC India Private Limited

Welcome Back!

Sign in to your account

Lost your password?